Who Paid My Doc
Flebogamma DIF
Biological Immnunology
NDC 61953-0005-1
General payments
$12,126
Research payments
$106,561
Through program year 2024, $12,126 in general payments and $106,561 in research payments were reported against Flebogamma DIF (Immnunology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $3,216 | 1 |
| 2024 | Research | $48,489 | 6 |
| 2023 | General | $8,870 | 3 |
| 2023 | Research | $11,645 | 11 |
| 2022 | General | $40 | 1 |
| 2022 | Research | $46,426 | 40 |
Breakdown
Each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2024 where a state was reported.
Records
5 general · 57 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.